Engineered antibody maker KaloBios takes on $20M for clinical trials

South San Francisco, Calif.-based KaloBios Pharmaceuticals, which develops non-human antibodies for use in human bodies, has taken $20 million in its fourth round of venture funding.

KaloBios is currently going through seven first- and second-phase clinical trials for two drugs and is working on a third,… Continue Reading

Life sciences briefing: Wednesday, Dec. 19, 2007

Life sciences briefing: Wednesday, Dec. 19, 2007

TODAY’S HEADLINES:

Gene-silencing developer Santaris raises €20M (PDF release)
Consumer-driven healthcare manager RedBrick Health prescribed $15M (release)
Cardiac Dimensions takes in $36M for heart-valve device (release)
TcLand Expressions gets €8.2M for biomarkers (PDF release)
TheraQuest Bio gets $3M for pain drugs (release)
Brain-software maker NeuroTrax visualizes $1.5M (VentureWire)
ActivBiotics selling off assets… Continue Reading

Life sciences briefing: Thursday, Aug. 23, 2007

Life sciences briefing: Thursday, Aug. 23, 2007

(UPDATED at 6:30am PT on Friday: See below.)

Featured companies: DNA2.0, Globus Medical, Inotek Pharmaceuticals, Operon Biotechnologies, PleuraFlow

Globus Medical raises $110M for spinal implants — Globus Medical, an Audubon, Pa., developer of spinal implants, raised $110 million in a fifth financing round. Investors included Clarus Ventures, AIG SunAmerica… Continue Reading

3D mobile phone company, Gemini, raises $5M more

Gemini Mobile Technologies, a San Mateo, Calif. developer of wireless software that provides a 3D environment in which users can chat, share photos and shop on their phones, said it has raised an additional financing round of $5 million.

Backers are Japan’s Access Co., Aplix Corp.,… Continue Reading